Chronic eye diseases: AMD (H35.3), glaucoma (H40), diabetic retinopathy (H36.0) H35.3 H40 H36.0
Conditions
Interventions
Group 1: Patients with chronic eye diseases (including AMD/glaucoma) will be assessed once through in-depth interviews and questionnaires, and continuously over a period of one week via digital data c
Sponsors
Universitätsklinikum Bonn
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults capable of giving informed consent (= 18 years of age) with retinal diseases (particularly diabetic eye diseases, retinal vein occlusion, neovascular AMD) or glaucoma
Exclusion criteria
Exclusion criteria: Adults with insufficient understanding of the German language Children and adolescents (< 18 years) Inability to participate due to an additional disability (e.g., severe intellectual disability) Other serious mental illnesses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Development of patient-relevant PerfOs based on smartphone usage and accelerometer data for use in chronic eye diseases that primarily affect central vision (e.g., AMD) or peripheral vision (e.g., glaucoma), with a focus on the domains of reading and mobility 2. Initial cross-sectional and longitudinal validation of the digital PerfOs using a clinical cohort (construct validity, criterion validity, sensitivity to change) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Stratification of the quality of endpoints and various PerfO endpoint categories (smartphone, accelerometer) compared to relevant PROMs (Vision Impairment in Low Luminance (VILL) questionnaire) 2. Generation of innovative, ophthalmologically relevant accelerometer-based endpoints obtained using the activPAL 3. Development of endpoints for the creation of a smartphone application for self-monitoring of digital behaviors as an ophthalmological study endpoint | — |
Countries
Germany
Contacts
Public ContactJan Henrik Terheyden
Uniklinikum Bonn
Outcome results
None listed